The field of diabetes treatment has seen a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide are rapidly emerging as potential game-changers. This pair https://keithweiu276282.bcbloggers.com/37930379/upcoming-glp-1-receptor-agonists-retatrutide-and-trizepatide